Embedding assessment of liver fibrosis into routine diabetic review in primary care
Background & Aims: Individuals with type 2 diabetes (T2DM) are at high risk of developing non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis/cirrhosis. Screening patients with T2DM and normal liver enzymes for NAFLD in primary care remains contentious. Our aim was to develop and...
Main Authors: | Dina Mansour, Allison Grapes, Marc Herscovitz, Paul Cassidy, Jonathan Vernazza, Andrea Broad, Quentin M. Anstee, Stuart McPherson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555921000690 |
Similar Items
-
Estimating steatosis and fibrosis
by: Karlas, Thomas, et al.
Published: (2015) -
What we need to know when performing and interpreting US elastography
by: So Hyun Park, et al.
Published: (2016-09-01) -
Comparison of Visual Transient Elastography and Shear Wave Elastography in Evaluating Liver Fibrosis in Patients with Chronic Liver Disease
by: Yang J, et al.
Published: (2021-07-01) -
Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)
by: J. C. Marín-Gabriel, et al.
Published: (2009-11-01) -
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)